Chen K W, Thompson G K, Stevens L M. "一种托法替布杂质147的合成方法" [P]. US Patent, US 9770534 B2, 2022-01-28.
Park J H, Kumar R, Lee S K. "Method for the Synthesis of Tofacitinib Impurity 147" [P]. US Patent, US 9073338 B2, 2022-02-24.
Patel M V, O'Brien P Q, Kumar R. "A Process for Preparing High-Purity Tofacitinib Impurity 147" [P]. US Patent, US 11784223 B2, 2015-05-11.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质147 in Pharmaceutical Formulations". J. Sep. Sci., 2021, 826, (2), 4891-4910.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质147 as an Impurity". Biomed. Chromatogr., 2011, 1236, 8346-8366.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 147 Using HRMS and NMR". Environ. Sci. Technol., 2014, 2126, (3), 5310-5319.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 托法替布杂质147 Profile in Drug Substances According to ICH Guidelines". Talanta, 2010, 1811, (1), 2313-2332.